A black, green, and blue graphic titled, “Advancing Organ-Chips in Resource-Limited Settings.” The following points are listed under benefits to be gained: Reduced reliance on costly animal research infrastructure; More accurate modeling of region-specific health burdens; More efficient use of physical infrastructure; Greater scalability and amenability to automation; Enhanced predictive power of preclinical testing; Greater participation in global biomedical research. The following points are listed under strategies for implementation: Establishment of regional manufacturing hubs to lower costs and reduce the need for device importation; Development of international training partnerships to build local expertise and support sustainable knowledge transfer; Advancement of modular, user-friendly device designs to decrease technical barriers; Alignment with international regulatory standards to facilitate validation while ensuring consistency. Adapted from Cabrera & de Valle, 2025; DOI: 10.3389/frlct.2025.1669220.
Experiments on animals aren't just ethically & scientifically flawed, they're costly. 💲
Animal facilities are expensive to build & run, especially in low-resource settings.
Affordable alternatives like #organsonchips can reduce suffering, boost relevance, & support global equity in science. 🧪